Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors.
Anna Maria MartoneMatteo TosatoFrancesca CiciarelloVincenzo GalluzzoMaria Beatrice ZazzaraCristina PaisGiulia SaveraRiccardo CalvaniEmanuele MarzettiMaria Camprubi RoblesMaria RamirezFrancesco Landinull nullPublished in: Journal of cachexia, sarcopenia and muscle (2022)
Sarcopenia identified according to the EWGSOP2 criteria is high in patients recovered from COVID-19 acute illness, particularly in those who had experienced the worst clinical picture reporting the persistence of fatigue and dyspnoea. Our data suggest that sarcopenia, through the persistence of inflammation, could be the biological substrate of long COVID-19 syndrome. Physical activity, especially if associated with adequate nutrition, seems to be an important protective factor.
Keyphrases
- coronavirus disease
- sars cov
- risk factors
- physical activity
- skeletal muscle
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- oxidative stress
- respiratory syndrome coronavirus
- case report
- liver failure
- community dwelling
- peritoneal dialysis
- prognostic factors
- emergency department
- sleep quality
- body mass index
- respiratory failure
- electronic health record
- drug induced
- big data
- deep learning
- machine learning
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation